BridgeBio Pharma, Inc. Contracts & Agreements

80 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration Agreement, by and between BridgeBio Gene Therapy, LLC and Catalent Maryland, Inc., formerly Paragon Bioservices, Inc., dated December 31, 2019
Collaboration Agreements
BridgeBio Pharma, Inc.
Biotechnology
MD
2020
Transaction Agreement, dated as of August 16, 2024, by and among BridgeBio Pharma, Inc., Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global...
Investment Agreements
BridgeBio Pharma, Inc.
2024
Amended and Restated Limited Liability Company Agreement of GondolaBio, LLC, dated as of August 16, 2024
Limited Liability Company Agreements
BridgeBio Pharma, Inc.
2024
2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2024
Underwriting Agreement, dated as of March 5, 2024, by and among the Company, J.P. Morgan Securities LLC, Cantor Fitzgerald & Co. and Mizuho Securities USA LLC, as representatives...
Underwriting Agreements
BridgeBio Pharma, Inc.
2024
Letter Agreement, Amendment #1 thereto, and Amendments to License Agreement between QED Therapeutics, Inc. and Novartis International Pharmaceutical Ltd., dated May 4, 2018,...
License Agreements
BridgeBio Pharma, Inc.
2024
Amendment to Employment Agreement, between BridgeBio Services, Inc. and Brian Stephenson, dated February 21, 2024
Employment Agreements
BridgeBio Pharma, Inc.
2024
Second Amendment, effective as of August 15, 2023, to the Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford...
BridgeBio Pharma, Inc.
2023
Securities Purchase Agreement, dated September 25, 2023, by and among BridgeBio Pharma, Inc. and the purchasers party thereto
Purchase Agreements
BridgeBio Pharma, Inc.
2023
Registration Rights Agreement, dated September 25, 2023, by and among BridgeBio Pharma, Inc. and the purchasers party thereto
Registration Rights Agreements
BridgeBio Pharma, Inc.
2023
Form of Restricted Stock Unit Award Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
2023
Form of Restricted Stock Award Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
2023
Form of Non-Qualified Stock Option Agreement under BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (2023 Form)
Stock Agreements
BridgeBio Pharma, Inc.
2023
Form of Restricted Stock Unit Award Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan (2023 Form)
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2023
Form of Restricted Stock Award Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan (2023 Form)
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2023
Form of Non-Qualified Stock Option Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan (2023 Form)
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2023
Form of Non-Qualified Stock Option Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan for Board of Directors (2023 Form)
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2023
Underwriting Agreement, dated as of March 7, 2023, by and among the Company, Goldman Sachs & Co. LLC, Evercore Group L.L.C. and Morgan Stanley & Co. LLC, as representatives of the...
Underwriting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2023
Description of Securities
BridgeBio Pharma, Inc.
2022
Amended and Restated 2021 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2022
Amended and Restated Director Compensation Policy
Compensation Agreements
BridgeBio Pharma, Inc.
Biotechnology
2022
Loan and Security Agreement, among U.S. Bank National Association in its capacity as Administrative Agent and Collateral Agent, the Lenders party thereto, the Registrant, and...
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2022
Amended and Restated Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
2021
Sixth Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of April 13, 2021
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Amended and Restated Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
2021
Description of Securities
BridgeBio Pharma, Inc.
2021
Third Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of March 2, 2020
Loan Agreements
BridgeBio Pharma, Inc.
2021
Fifth Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of January 25, 2021
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2021
Underwriting Agreement, dated as of February 11, 2021, by and among the Company, the Selling Stockholder and Goldman Sachs & Co. LLC, as the representative of the several...
Underwriting Agreements
BridgeBio Pharma, Inc.
2021
Indenture, dated as of January 28, 2021, by and between BridgeBio Pharma, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
BridgeBio Pharma, Inc.
2021
Form of Confirmation for Capped Call Transactions
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
Purchase Agreement, dated January 25, 2021, by and among BridgeBio Pharma, Inc. and J.P. Morgan Securities LLC and Mizuho Securities USA LLC, as representatives of the several...
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2021
Amended and Restated 2019 Employee Stock Purchase Plan, effective December 12, 2019
Stock Agreements
BridgeBio Pharma, Inc.
2020
Agreement and Plan of Merger, dated as of October 5, 2020, by and among BridgeBio Pharma, Inc., Eidos Therapeutics, Inc., Globe Merger Sub I, Inc. and Globe Merger Sub II, Inc
Merger Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2020
Form of Confirmation for Capped Call Transactions
BridgeBio Pharma, Inc.
Biotechnology
2020
Indenture, dated as of March 9, 2020, by and between BridgeBio Pharma, Inc. and U.S. Bank National Association, as Trustee
Indenture Agreements
BridgeBio Pharma, Inc.
2020
Purchase Agreement, dated March 4, 2020, by and among BridgeBio Pharma, Inc. and J.P. Morgan Securities LLC and BofA Securities, Inc., as representatives of the several Initial...
Purchase Agreements
BridgeBio Pharma, Inc.
2020
Description of Securities
BridgeBio Pharma, Inc.
2020
Fourth Amendment to the Exclusive License Agreement, between The Regents of the University of California and TheRas, Inc., dated December 16, 2019
License Agreements
BridgeBio Pharma, Inc.
2020
Consulting Agreement, between Jennifer E. Cook and the Registrant, effective as of October 14, 2019
Consulting Agreements
BridgeBio Pharma, Inc.
Biotechnology
2020
Offer Letter, between BridgeBio Pharma, Inc. and James C. Momtazee, dated February 23, 2020
BridgeBio Pharma, Inc.
Biotechnology
2020
Director Compensation Policy
Compensation Agreements
BridgeBio Pharma, Inc.
2020
Loan and Security Agreement dated November 13, 2019 between Eidos Therapeutics, Inc., a partially owned subsidiary of Registrant, as borrower, Silicon Valley Bank and Hercules...
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Offer Letter, between BridgeBio Pharma, Inc. and Brian Stolz, dated September 19, 2019
BridgeBio Pharma, Inc.
2019
Offer Letter, between and BridgeBio Services, Inc. and Yi Ching Yau, dated September 9, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
License Agreement, by and between the Registrant and Alexion Pharma International Operations Unlimited Company, dated September 9, 2019
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Registration Rights Agreement
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Form of Underwriting Agreement
Underwriting Agreements
BridgeBio Pharma, Inc.
2019
Specimen Common Stock Certificate
Stock Agreements
BridgeBio Pharma, Inc.
2019
Form of Registration Rights Agreement, among the Registrant and certain of its shareholders, to be in effect immediately prior to completion of this offering
Registration Rights Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
2019 Stock Option and Incentive Plan and forms of award agreements thereunder
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
2019 Employee Stock Purchase Plan
Stock Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Senior Executive Cash Incentive Bonus Plan
Bonus & Incentive Agreements
BridgeBio Pharma, Inc.
2019
Form of Indemnification Agreement, between the Registrant and each of its directors
Indemnification Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Form of Indemnification Agreement, between the Registrant and each of its executive officers
Indemnification Agreements
BridgeBio Pharma, Inc.
2019
Form of Tax Sharing Agreement, between the Registrant and each of its subsidiaries
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Indemnification Agreement, between BridgeBio Pharma LLC and KKR Genetic Disorder, L.P., dated March 26, 2016
Indemnification Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Offer Letter, between BridgeBio Services, Inc. and Neil Kumar, dated December 14, 2017
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Brian Stephenson, dated October 28, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between Eidos Therapeutics, Inc. and Uma Sinha, dated June 1, 2016, as amended on May 24, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Charles Homcy, dated February 20, 2019
BridgeBio Pharma, Inc.
2019
Offer Letter, between BridgeBio Services, Inc. and Richard Scheller, dated April 5, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Michael Henderson, dated March 22, 2016, as amended on May 5, 2017
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Cameron Turtle, dated December 13, 2016, as amended on May 5, 2017
BridgeBio Pharma, Inc.
2019
Offer Letter, between Eidos Therapeutics, Inc. and Cameron Turtle, dated June 13, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Fourth Amended and Restated Limited Liability Company Agreement, dated November 20, 2018, by and among BridgeBio Pharma LLC and its members
Limited Liability Company Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Form of Registration Rights Agreement, among the Registrant and certain of its shareholders, to be in effect immediately prior to completion of this offering
Registration Rights Agreements
BridgeBio Pharma, Inc.
2019
Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of June 19, 2018
Loan Agreements
BridgeBio Pharma, Inc.
2019
First Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital, Inc., dated as of December 28, 2018
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Lease Agreement, between BridgeBio Pharma LLC and Michael J. Harbour, dated as of March 23, 2017
Lease Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford Junior University, effective as of April 10, 2016, as...
BridgeBio Pharma, Inc.
2019
License Agreement, between QED Therapeutics, Inc. and Novartis International Pharmaceutical Ltd., dated as of January 29, 2018
License Agreements
BridgeBio Pharma, Inc.
2019
Asset Purchase Agreement, among BridgeBio Pharma LLC, Origin Biosciences, Inc., and Alexion Pharma Holding Unlimited Company, dated as of June 7, 2018
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Asset Purchase Agreement, among Phoenix Tissue Repair, Inc., Shire Human Genetic Therapies, Inc., and Lotus Tissue Repair, Inc., dated as of July 21, 2017
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2019
Exclusive License Agreement, between The Regents of the University of California and TheRas, Inc., dated September 28, 2016, as amended by First Amendment effective January 10,...
License Agreements
BridgeBio Pharma, Inc.
2019
Collaboration and License Agreement, between Navire Pharma, Inc. (formerly known as PTP Pharmaceuticals, Inc.) and the Board of Regents of the University of Texas System and The...
Collaboration Agreements
BridgeBio Pharma, Inc.
2019
Exclusive Patent License Agreement, between The Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc., under sponsorship from the...
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
2019
Cell Line License Agreement, by and between Life Technologies Corporation and BridgeBio Services, Inc., effective as of November 15, 2018
License Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Second Amendment to the Loan and Security Agreement, between BridgeBio Pharma LLC and Hercules Capital Inc., dated as of May 17, 2019
Loan Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2019
Option Agreement, among PellePharm, Inc., Leo Pharma A/S and Leo Spiny Merger Sub, Inc., dated as of November 19, 2018, as amended on March 13, 2019
Merger Agreements
BridgeBio Pharma, Inc.
2019